Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

IBUPROFEN Drug Profile

« Back to Dashboard

What is the patent landscape for Ibuprofen, and when can generics launch?

Ibuprofen is a drug marketed by Amneal Pharms, Ani Pharms Inc, Vintage Pharms, Marksans Pharma, Watson Labs, Sandoz, Sun Pharm Inds, Superpharm, LNK, Dr Reddys Labs Inc, Granules India Ltd, Aiping Pharm Inc, Perrigo R And D, Actavis Mid Atlantic, Perrigo, Ohm Labs, Mcneil, Purepac Pharm, Halsey, Par Pharm, Lederle, Strides Pharma, Contract Pharmacal, Northstar Hlthcare, Amneal Pharms Ny, Aurolife Pharma Llc, P And L Dev Llc, Ivax Sub Teva Pharms, Teva, Mylan Pharms Inc, Hi-tech Pharmacal, Abbott, Mylan, Tris Pharma Inc, Avema Pharma, Dr Reddys La, OHM, Leiner, Pliva, Humanwell Puracap, Granules India, J And J Consumer Inc, Bionpharma Inc, Merro Pharm, Sofgen Pharms, Dr Reddys Labs Ltd, and Exela Pharma Science. and is included in one hundred and forty-three NDAs.

The generic ingredient in IBUPROFEN is ibuprofen sodium. There are sixty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ibuprofen sodium profile page.

Summary for Tradename: IBUPROFEN

Suppliers / Packagers: see list242
Bulk Api Vendors: see list119
Clinical Trials: see list197
Patent Applications: see list9,521
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:IBUPROFEN at DailyMed

Pharmacology for Tradename: IBUPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Marksans Pharma
TABLET;ORAL091237-001Feb 8, 2011OTCNoNo► Subscribe► Subscribe
Amneal Pharms
SUSPENSION;ORAL200457-001Aug 18, 2011OTCNoNo► Subscribe► Subscribe
Par Pharm
TABLET;ORAL070329-001Aug 6, 1985DISCNNoNo► Subscribe► Subscribe
Granules India Ltd
TABLET;ORAL091625-002Sep 15, 2015ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
diphenhydramine citrate; ibuprofen
TABLET;ORAL090619-001Jul 8, 2009OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus